Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,500
Closed -$283K 55
2022
Q1
$283K Hold
1,500
0.01% 49
2021
Q4
$366K Hold
1,500
0.02% 48
2021
Q3
$291K Hold
1,500
0.01% 48
2021
Q2
$280K Hold
1,500
0.01% 53
2021
Q1
$236K Hold
1,500
0.01% 61
2020
Q4
$248K Hold
1,500
0.01% 56
2020
Q3
$248K Hold
1,500
0.02% 55
2020
Q2
$206K Buy
+1,500
New +$196K 0.02% 55
2016
Q1
Sell
-15,591
Closed -$747K 122
2015
Q4
$747K Buy
15,591
+313
+2% +$14.1K 0.04% 61
2015
Q3
$629K Buy
15,278
+3,287
+27% +$152K 0.03% 65
2015
Q2
$578K Buy
11,991
+3,500
+41% +$167K 0.03% 76
2015
Q1
$393K Buy
+8,491
New +$383K 0.02% 96

Other funds holding ZTS

Capital Counsel's ZTS Position: Q2 2022 in Review

Capital Counsel sold out of Zoetis (ZTS) in Q2 2022, closing a stake of 1,500 shares — an estimated $283K sold.

Capital Counsel first reported a position in ZTS in Q1 2015 and held it in 12 quarters. The position peaked at $747K in Q4 2015. 1,563 funds tracked by Wall St. Rank hold ZTS as of Q2 2022.

  • Capital Counsel reported no remaining Zoetis position as of Q2 2022 after selling out during the quarter.
  • Capital Counsel sold 1,500 Zoetis shares in Q2 2022, an estimated $283K.
  • Capital Counsel first reported a position in Zoetis in Q1 2015 and held it in 12 quarters.
  • Capital Counsel's Zoetis position peaked at $747K in Q4 2015.
  • 1,563 funds tracked by Wall St. Rank held Zoetis as of Q2 2022.

Based on Capital Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.